A drug-testing lab in dispute with regulators sues the USP over criticism of its methods.
PBMs will have to display TrumpRx drug prices, while Bristol's Zenbexus gains accelerated approval and Novartis wins a UK patent fight over Entresto, in a biotech news roundup.
FDA intends to take action against non-FDA-approved GLP-1 drugs.